Research database

On this basis, the project intends to develop an integrated platform including the contrast medium, an external magnetic actuation system, EEG acquisition hardware, and dedicated signal processing and reconstruction algorithms. The technological objective is to demonstrate, in relevant environments and through an initial clinical validation, that the solution can overcome the limitations of conventional EEG in terms of spatial resolution and sensitivity to deep sources, while preserving the safety, non-invasiveness, and operational practicality required for future clinical use. The project also has a strong entrepreneurial dimension. The results will be valorized through the creation of a startup that will act as the main vehicle for industrial exploitation, while an industrial partner with consolidated expertise in EEG and neurotechnology will provide essential technical and business competences for system integration, product positioning, and the definition of the route to market. The project will therefore achieve not only technological maturation, but also a concrete transition toward investability, clinical validation, and the future commercialization of a radically new neurotechnology. The first applications under consideration include drugresistant epilepsy, functional mapping, and, in a longer-term perspective, advanced brain-computer interface platforms. In this way, the project is positioned at the intersection of biomedical research, medical devices, and high-value neurotechnology.